- Market Realist•9 hours ago
With the launch of Orkambi, which caters to a larger population base, Kalydeco’s contribution dropped to 42.8% in 1Q16 from 93.3% in 2Q15.
Vertex Pharmaceuticals IncorporatedNasdaqGS
After hours: 95.790.02 (0.02%) as of 4:41 PM EDT
|Bid||88.00 x 500|
|Ask||105.50 x 200|
|52wk Range||75.90 - 143.45|
|Day's Range||93.46 - 96.52|
|Avg Vol (3m)||1,666,087|
As of 4:00 PM EDT. Market closed.